World

Sheikh Zayed Housing Programme issued 945 decisions worth AED 749 mn since beginning of 2023

May 02, 2023

Abu Dhabi [UAE], May 2: Sheikh Zayed Housing Programme (SZHP), an initiative under the Ministry of Energy and Infrastructure (MoEI), has issued 945 decisions for housing aid valued at AED 749 million so far in 2023. This includes decisions to provide either government houses or home finance jointly with banks and represents 32 percent of the total 3,000 decisions that the Programme aims to issue in 2023.
Eng Mohamed Al Mansouri, Director of SZHP, said: "We continue to work relentlessly and join forces with our stakeholders to bring government housing plans and strategies into fruition, to improve the social wellbeing and living conditions of UAE people.
"Providing decent residences for Emiratis is at the top of our leadership's priorities, as the prosperity of the people is a pillar of the country's sustainable development, in line with the government objectives for the next 50 years. To contribute to the happiness of UAE citizens, SZHP has devised plans and launched qualitive initiatives and projects to step up residential stability and meet the needs of Emiratis who applied for housing aid. For the next phase, we seek to align efforts among the government, the private sector, and the local community to better serve the Programme beneficiaries."
Source: Emirates News Agency

More news

Metropolis Healthcare unveils Key Findings from Molecular Genomics Study in honour of Lung Cancer Awareness Month

Mumbai (Maharashtra) [India], November 22: Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 million new cases diagnosed annually, contributing to 18% of all cancer-related deaths, according to the International Agency for Research on Cancer. In India, it continues to be a leading cause of cancer-related mortality. However, advancements in early detection and new treatment options, particularly genetic profiling, are improving survival rates. These innovations are part of precision oncology, a rapidly growing field that customizes treatments based on a patient's unique genetic makeup, enabling personalized care.

Nov 22, 2024